X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (139) 139
Newspaper Article (31) 31
Publication (8) 8
Conference Proceeding (7) 7
Book / eBook (6) 6
Book Review (6) 6
Art (4) 4
Book Chapter (4) 4
Patent (2) 2
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (79) 79
humans (74) 74
male (30) 30
female (28) 28
middle aged (27) 27
oncology (24) 24
hematology (23) 23
cancer (20) 20
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (20) 20
adult (19) 19
aged (19) 19
animals (16) 16
imatinib mesylate (16) 16
antineoplastic agents - therapeutic use (15) 15
mice (14) 14
mutation (14) 14
chronic myelogenous leukemia (13) 13
chronic myeloid leukemia (12) 12
chronic myeloid-leukemia (12) 12
treatment outcome (12) 12
benzamides (11) 11
cell line, tumor (11) 11
leukemia, myelogenous, chronic, bcr-abl positive - genetics (11) 11
surgery (11) 11
abridged index medicus (10) 10
follow-up studies (10) 10
leukemia (10) 10
chemotherapy (9) 9
immunology (9) 9
piperazines - therapeutic use (9) 9
pyrimidines - therapeutic use (9) 9
follow-up (8) 8
fusion proteins, bcr-abl - genetics (8) 8
imatinib (8) 8
protein kinase inhibitors - therapeutic use (8) 8
survival (8) 8
therapy (8) 8
adolescent (7) 7
antineoplastic agents - pharmacology (7) 7
biochemistry & molecular biology (7) 7
care and treatment (7) 7
cell biology (7) 7
leukemia, myelogenous, chronic, bcr-abl positive - pathology (7) 7
polymerase chain reaction (7) 7
prognosis (7) 7
retrospective studies (7) 7
transplantation (7) 7
aged, 80 and over (6) 6
analysis (6) 6
apoptosis (6) 6
clinical trials (6) 6
drug administration schedule (6) 6
expression (6) 6
hemic and lymphatic diseases (6) 6
medicine (6) 6
molecular sequence data (6) 6
protein kinase inhibitors - pharmacology (6) 6
toxicity (6) 6
activation (5) 5
antineoplastic agents - administration & dosage (5) 5
antineoplastic agents - adverse effects (5) 5
base sequence (5) 5
bcr-abl (5) 5
disease (5) 5
drug resistance, neoplasm (5) 5
drug resistance, neoplasm - drug effects (5) 5
histocompatibility testing (5) 5
kidney transplantation - immunology (5) 5
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (5) 5
leukemia, myelogenous, chronic, bcr-abl positive - mortality (5) 5
lung neoplasms - pathology (5) 5
multidisciplinary sciences (5) 5
piperazines - administration & dosage (5) 5
piperazines - adverse effects (5) 5
protein binding (5) 5
protein kinase inhibitors - administration & dosage (5) 5
protein-tyrosine kinases - antagonists & inhibitors (5) 5
proteins (5) 5
pyrimidines - administration & dosage (5) 5
pyrimidines - adverse effects (5) 5
recurrence (5) 5
research article (5) 5
resistance (5) 5
rna (5) 5
time factors (5) 5
tissue donors (5) 5
transfection (5) 5
tumors (5) 5
amino acid sequence (4) 4
aniline compounds - therapeutic use (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
article (4) 4
cadaver (4) 4
carrier proteins - genetics (4) 4
carrier proteins - metabolism (4) 4
cell proliferation (4) 4
cml (4) 4
dasatinib (4) 4
drug therapy (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica, ISSN 0390-6078, 2017, Volume 102, Issue 1, pp. 4 - 6
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2014, Volume 106, Issue 2, pp. djt378 - djt378
Journal Article
Nature Genetics, ISSN 1061-4036, 01/2013, Volume 45, Issue 1, pp. 18 - 24
Journal Article
Scientific Reports, ISSN 2045-2322, 04/2017, Volume 7, Issue 1, pp. 46290 - 46290
The complicated, evolving landscape of cancer mutations poses a formidable challenge to identify cancer genes among the large lists of mutations typically... 
Mutation | Cancer | Index Medicus
Journal Article
American Journal of Hematology, ISSN 0361-8609, 02/2015, Volume 90, Issue 2, pp. 156 - 161
Journal Article
Journal Article
HAEMATOLOGICA, ISSN 0390-6078, 01/2017, Volume 102, Issue 1, pp. 4 - 6
Journal Article
American Journal of Hematology, ISSN 0361-8609, 10/2015, Volume 90, Issue 10, pp. 910 - 914
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2012, Volume 87, Issue 11, pp. E125 - E128
BCR/ABL (Breakpoint Cluster Region protein/Abelson tyrosine-protein kinase 1) kinase domain (KD) mutations represent the most frequently described mechanism of... 
CELLS | IN-VITRO | IMATINIB | ALPHA-1-ACID GLYCOPROTEIN | RESISTANCE | MECHANISMS | MUTATIONS | HEMATOLOGY | BCR-ABL INHIBITOR | CHRONIC MYELOID-LEUKEMIA | T315I MUTANT | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Antineoplastic Agents - therapeutic use | Structure-Activity Relationship | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Sequence Analysis, Protein | Protein Kinase Inhibitors - chemistry | Protein-Tyrosine Kinases - genetics | Transfection | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Protein-Tyrosine Kinases - chemistry | Antineoplastic Agents - pharmacology | Cell Culture Techniques | Tumor Cells, Cultured | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Fusion Proteins, bcr-abl - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Mutagenesis, Site-Directed | Antineoplastic Agents - chemistry | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Drug Resistance, Neoplasm - genetics | Fusion Proteins, bcr-abl - genetics | Animals | Protein Kinase Inhibitors - therapeutic use | Fusion Proteins, bcr-abl - antagonists & inhibitors | Precursor Cell Lymphoblastic Leukemia-Lymphoma - enzymology | Mice | Protein Kinase Inhibitors - pharmacology | Mutation | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2013, Volume 8, Issue 9, pp. e75280 - e75280
CK2 is a pivotal pro-survival protein kinase in multiple myeloma that may likely impinge on bortezomib-regulated cellular pathways. In the present study, we... 
CANCER-CELLS | ACTIVATION | SIGNALING PATHWAY | INDUCED APOPTOSIS | PHOSPHORYLATION | MULTIDISCIPLINARY SCIENCES | THERAPEUTIC TARGET | TRANSCRIPTION | PROLIFERATION | PROTEASOME INHIBITORS | EXPRESSION | Immunohistochemistry | Boronic Acids - metabolism | Apoptosis - drug effects | Humans | Molecular Sequence Data | NF-kappa B - metabolism | DNA Primers - genetics | Pyrazines - metabolism | Casein Kinase II - genetics | Leukocytes, Mononuclear | Multiple Myeloma - drug therapy | RNA Interference | Adenosine Triphosphate - metabolism | Base Sequence | Real-Time Polymerase Chain Reaction | STAT3 Transcription Factor - metabolism | Bortezomib | Casein Kinase II - antagonists & inhibitors | Lymphoma, Mantle-Cell - drug therapy | Blotting, Western | Analysis of Variance | Signal Transduction - drug effects | Cell Line, Tumor | Signal Transduction - physiology | Pyrazines - pharmacology | Naphthyridines - pharmacology | Boronic Acids - pharmacology | Protein kinase C | Transcription factors | Phosphorylation | Laboratories | Toxicity | Multiple myeloma | Cytotoxicity | Kinases | Casein kinase II | Proteins | Signal transduction | Mitochondria | Immunology | Pathways | Cascades | Bone marrow | Inhibition | Mantle | Stresses | NF-κB protein | Cell survival | Cytokines | Hematology | Stat3 protein | Hsp70 protein | Tumor cell lines | Survival | Lymphoma | Stress | Medicine | Pathology | Signaling | Inhibitors | Lymphocytes B | Cell death | Cell lines | Mantle cell lymphoma | Interferon | Lymphomas | Endoplasmic reticulum | Tumors | Apoptosis | Index Medicus
Journal Article
Scientific reports, ISSN 2045-2322, 05/2017, Volume 7, Issue 1, pp. 46823 - 46823
This corrects the article DOI: 10.1038/srep46290. 
Journal Article
Neoplasia, ISSN 1476-5586, 05/2018, Volume 20, Issue 5, pp. 467 - 477
Journal Article
Neoplasia, ISSN 1476-5586, 2013, Volume 15, Issue 5, pp. 511 - IN17
Journal Article